Keyphrases
Mycobacterium Tuberculosis (M. tb)
100%
Tuberculosis
46%
Echinocandins
38%
Staphylococcus Aureus
37%
Relapsed or Refractory multiple Myeloma
34%
Multiple Myeloma
33%
Candida Albicans (C. albicans)
31%
Caspofungin
24%
Aspergillus Fumigatus
20%
Lenalidomide
20%
Methicillin-resistant Staphylococcus Aureus
19%
New York City
19%
Mouse Model
17%
C.albicans
17%
Mycobacterium Abscessus
16%
Carfilzomib
16%
Plasma Membrane H+-ATPase
16%
Candida
15%
Candida Glabrata
15%
Drug Resistance
15%
Multidrug-resistant
15%
Escherichia Coli
14%
Saccharomyces Cerevisiae
14%
Antibiotics
14%
T Cells
13%
ATP Synthase
13%
Pharmacokinetics
13%
Antimycobacterial Activity
13%
Lung
13%
Micafungin
13%
Mycobacterium
13%
Virulence
12%
Bortezomib
12%
Tumor
12%
Resistant Strains
12%
Echinocandin Resistance
12%
Research Partnerships
12%
Childhood Arthritis
12%
Rheumatology Research
12%
Candida Species
12%
Gene Expression
12%
Glucan Synthase
12%
H+-ATPase
11%
FoF1-ATP Synthase
11%
Amphotericin B
11%
COVID-19
11%
Clinical Trials
11%
Fungi
11%
C.glabrata
11%
Plasmid
11%
United States
11%
Pyrazinamide
11%
Resistance Mechanisms
10%
IS6110
10%
Murine Model
10%
Klebsiella Pneumoniae (K. pneumoniae)
10%
Lung Cancer Screening
10%
Klebsiella Pneumoniae Carbapenemase
10%
Pomalidomide
9%
Bacillus
9%
FKS1
9%
Fumigatus
9%
Genotype
9%
Fluconazole
9%
Antifungal Therapy
9%
Toxic Shock Syndrome toxin-1 (TSST-1)
9%
Mycobacterium Smegmatis
9%
Graft-versus-host Disease (GvHD)
9%
Trypanosoma Cruzi (T. cruzi)
8%
Mycobacterium Bovis BCG
8%
Susceptibility Testing
8%
Rifampin
8%
Neutropenic
8%
FKS mutation
8%
ATP Hydrolysis
8%
Tuberculosis Drugs
8%
Confidence Interval
8%
Dendritic Cells
8%
Molecular Epidemiology
8%
Antifungal Drugs
8%
Systemic Juvenile Idiopathic Arthritis (sJIA)
8%
Chagas Disease
7%
Myeloma
7%
CA-MRSA
7%
Bedaquiline
7%
Multidrug-resistant Tuberculosis (MDR-TB)
7%
Vancomycin
7%
Mechanism of Action
7%
Alzheimer's Disease
7%
Rapid Detection
7%
Anidulafungin
7%
Antifungal Activity
7%
Restriction Fragment Length Polymorphism
7%
AIDS/HIV
7%
Adipose Tissue
7%
Imprinted Genes
7%
Low-dose Dexamethasone
7%
CD8+ T Cells
7%
Antifungal Agents
7%
Dormancy
7%
Granuloma
7%
Environmental Influences on Child Health Outcomes
7%
Fungal Pathogens
7%
Liver
6%
Azoles
6%
Candida Auris
6%
Mycobacterium Tuberculosis Complex
6%
Pma1
6%
Transcription Factor
6%
Hematopoietic Stem Cells
6%
Echinocandin Susceptibility
6%
Tumor Necrosis Factor-α
6%
Invasive Pulmonary Aspergillosis
6%
Amino Acids
6%
In Vitro Activity
6%
Clinically Significant
6%
Multiple Myeloma Patients
6%
Antifungal Drug Resistance
6%
Trypanosoma Cruzi Infection
6%
Hematological Malignancies
6%
Mycobacterium Tuberculosis Strains
6%
Interleukin-6
6%
In Vivo Efficacy
6%
Inflammation
6%
Drug Discovery
6%
TCF1
6%
Kidney
6%
Cell Wall
6%
Tuberculosis Patients
6%
China
6%
Mycobacterium Tuberculosis Infection
6%
Wilms Tumor
6%
Macrophages
6%
Tuberculosis Treatment
6%
Bacillus Subtilis (B. subtilis)
6%
Core Genome multilocus Sequence Typing (cgMLST)
6%
Triazole
6%
Minimum Inhibitory Concentration
6%
Toxic Shock Syndrome
6%
Overexpression
6%
Aspergillus
6%
Aurès
6%
Mycobacterium Bovis
6%
Polymorphism
5%
Infected Mice
5%
Adverse Events
5%
Antifungal Susceptibility
5%
Spoligotyping
5%
Phosphorylation
5%
Chemotherapy
5%
Structure-activity Relationship
5%
DNA Sequencing
5%
Bloodstream Infection
5%
Hazard Ratio
5%
Infectious Diseases
5%
H19 Gene
5%
3-glucan
5%
Drug Distribution
5%
Clinical Outcomes
5%
Bacteremia
5%
Fluconazole Resistance
5%
Caseum
5%
Disseminated Candidiasis
5%
Cancer Patients
5%
Clinical Characteristics
5%
Mcr-1
5%
Amino Acid Substitution
5%
In Cancer
5%
Chagas Cardiomyopathy
5%
Parapsilosis
5%
Itraconazole
5%
Daratumumab
5%
High Dose
5%
Phase II Study
5%
Rifampicin
5%
Molecular Characterization
5%
3-D-glucan
5%
1,3-Dichloropropene (1,3-D)
5%
Azole Resistance
5%
Immunology and Microbiology
Mycobacterium Tuberculosis
78%
T Cell
50%
Candida Albicans
44%
Infectious Agent
42%
Multiple Myeloma
38%
Minimum Inhibitory Concentration
31%
Candida
30%
Staphylococcus Aureus
30%
Methicillin-Resistant Staphylococcus Aureus
26%
Cytotoxic T-Cell
24%
Cell Membrane
22%
Wild Type
21%
Aspergillus fumigatus
20%
Immunity
19%
Mycobacteria
16%
Immune Response
16%
Leporidae
16%
Lineages
15%
Plasmid
15%
Drug Resistance
15%
Dexamethasone
15%
Klebsiella pneumoniae
14%
Macrophage
14%
Escherichia coli
14%
Mycobacterium Bovis BCG
13%
Candida Glabrata
13%
Mouse Model
13%
T-Helper Cell
13%
Pharmacokinetics
12%
Saccharomyces cerevisiae
12%
Dendritic Cell
12%
Cell Wall
12%
Prevalence
12%
Cytokine
12%
Amino Acid
12%
Promoter Region
11%
Aspergillus
11%
Programmed Cell Death
11%
Dormancy
10%
Human Immunodeficiency Virus
10%
Mycobacterium Smegmatis
10%
Mycobacterium abscessus
10%
Granuloma
10%
Restriction Fragment Length Polymorphism
10%
Antifungal Resistance
9%
Gene Expression
9%
interferon
9%
Blood Plasma
9%
Chagas Disease
9%
Hematopoietic Cell
9%
Histone
9%
Precursor
9%
Matrix-Assisted Laser Desorption-Ionization
9%
CD8
8%
Lenalidomide
8%
Upregulation
8%
Peptides
8%
Graft-Versus-Host Disease
8%
Drug Megadose
8%
Transcription Factors
8%
Antifungal Activity
7%
COVID-19
7%
Cell Death
7%
Tumor Necrosis Factor
7%
DNA Sequence
7%
B Cell
7%
Cladistics
7%
Cell Differentiation
7%
Amino Acid Substitution
7%
Adoptive Immunity
7%
Smegma
7%
Biofilm
7%
Antimicrobial Resistance
7%
Stem Cell
7%
Bactericidal Activity
6%
Drug Sensitivity
6%
Antifungal Susceptibility
6%
Adipose Tissue
6%
Mycobacterium bovis
6%
Tumor Cell
6%
Allele
6%
Immunotherapy
6%
Overall Survival
6%
Antigen Specificity
6%
Oxidative Stress
6%
Neutrophil
6%
Regulator Gene
6%
Regulatory T Cell
6%
Real Time Polymerase Chain Reaction
6%
Molecular Beacon
6%
Amino Terminal Sequence
6%
Immunocompetent Cell
6%
Interleukin 6
6%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Candida Auris
5%
Myeloid
5%
Whole Cell
5%
Signal Transduction
5%
Bacillus subtilis
5%
Autophagy
5%
Childhood Arthritis
5%
Nontuberculous mycobacteria
5%
Juvenile Idiopathic Arthritis
5%
Host Cell
5%
Host Resistance
5%
Proteomics
5%
Imaging Mass Spectrometry
5%
Multilocus Sequence Typing
5%
Cancer Cell
5%
Medicine and Dentistry
Multiple Myeloma
49%
Diseases
33%
Neoplasm
27%
Infection
24%
Mycobacterium Tuberculosis
22%
Malignant Neoplasm
17%
COVID-19
17%
Rheumatology
16%
Carfilzomib
15%
Echinocandin
14%
Dexamethasone
14%
T Cell
13%
Arthritis
13%
Lenalidomide
13%
Pathogen
12%
Lung
11%
In Vitro
11%
Diagnosis
10%
Lung Cancer
10%
Myeloma
10%
Cancer
9%
Drug Resistance
9%
Overall Survival
9%
Breast Cancer
9%
Lung Cancer Screening
9%
Bortezomib
8%
Clinical Trial
8%
Metastatic Carcinoma
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Juvenile Idiopathic Arthritis
7%
Antifungal Resistance
7%
Surgery
7%
Pediatrics
7%
Biological Marker
7%
Innervation
7%
Chagas Disease
7%
Human Immunodeficiency Virus
7%
Injury
6%
Immunotherapy
6%
Prevalence
6%
Gut
6%
Adverse Event
6%
Progression Free Survival
6%
Low Drug Dose
6%
Gene Expression
6%
Odds Ratio
6%
Randomized Controlled Trial
5%
Gestational Age
5%
Melanoma
5%
Pharmacokinetics
5%
Emergency Department
5%
Stem Cell
5%
Child Health
5%
Neonatal Intensive Care Unit
5%
Serositis
5%
Lung Tuberculosis
5%
Patient Care
5%
Drug Sensitivity
5%
Messenger RNA
5%
Primary Health Care
5%
Cancer Cell
5%
Quality of Life
5%
Klebsiella pneumoniae
5%
Cohort Effect
5%